세계의 무혈청 배지 시장 : 규모 및 유형, 용도, 최종 사용자별 예측(2023년-2032년)

Serum-free media market size is expected to witness over 11% CAGR from 2023 to 2032 due to the increasing demand for advanced biopharmaceutical products. As companies continue to develop novel therapeutics, they are turning to serum-free culture systems to enhance productivity, consistency, and product quality.

For instance, Thermo Fisher Scientific's Gibco, offers a serum-free media solution formulated with essential nutrients and hormones, allowing for cell culture without the need for animal sera. The utilization of serum-free media in cell culture brings about a range of advantages, including enhanced consistency and productivity, as well as streamlined purification and downstream processing.

Additionally, growing concerns about the safety of serum-derived components and the potential for contamination have led to a shift towards serum-free media, which eliminates these risks. Moreover, the need for customized culture solutions and the development of chemically defined media for diverse research and production requirements will further bolster the market.

The overall serum-free media industry is classified based on type, application, end-user, and region.

The protein expression media segment is expected to register 11% CAGR from 2023 to 2032 driven by the expanding biopharmaceutical sector. Serum-free media designed specifically for protein expression are in high demand as researchers and manufacturers seek to optimize yields, quality, and consistency in the production of recombinant proteins, monoclonal antibodies, and other biologics. These media types are formulated to support high cell densities and increased protein productivity, making them essential in the biomanufacturing landscape.

Tissue engineering & regenerative medicine application segment is predicted to record 11.2% CAGR during 2023 to 2032. As regenerative therapies and tissue engineering solutions gain traction, the demand for serum-free media tailored for the culture and expansion of cells for clinical applications is on the rise. These media offer the precise formulation needed to support the growth and differentiation of stem cells and primary cells, facilitating advancements in areas such as organ transplantation, wound healing, and personalized medicine.

Asia Pacific serum-free media market size is expected to observe 11.5% CAGR from 2023 to 2032. Asia Pacific boasts a growing biotechnology and pharmaceutical sector, with increasing investments in R&D. There are rapid technological advancements and a shift toward biopharmaceutical production. The serum-free media market in Asia Pacific will further bolster with a growing population, rising healthcare investments, and the presence of key players.

Table of Contents

Chapter 1 Methodology

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Serum-free media industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Type trends
  • 2.1.4 Application trends
  • 2.1.5 End-user trends

Chapter 3 Serum-free Media Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of cell culture technologies for cell-based vaccines
    • 3.2.1.2 Rising prevalence of infectious and chronic diseases
    • 3.2.1.3 Rising R&D investments to develop novel regenerative therapies and disease specific solutions
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory guidelines
• 3.3 Growth potential analysis
  • 3.3.1 By type
  • 3.3.2 By application
  • 3.3.3 By end-user
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Serum-free Media Market, By Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by type
• 5.2 CHO cell culture
• 5.3 Protein expression media
• 5.4 Stem cell media
• 5.5 Immunology media
• 5.6 Hybridoma media
• 5.7 Other media types

Chapter 6 Serum-free Media Market, By Application, 2018 - 2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Biopharmaceutical production
• 6.3 Tissue engineering & regenerative medicine
• 6.4 Stem cell research & therapy
• 6.5 Other applications

Chapter 7 Serum-free Media Market, By End-user, 2018 - 2032 (USD Million)

• 7.1 Key trends, by end-user
• 7.2 Biopharmaceutical companies
• 7.3 Clinical research organizations
• 7.4 Academic research centers

Chapter 8 Serum-free Media Market, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Sartorius AG
• 9.2 Thermo Fisher Scientific Inc.
• 9.3 Merck KGaA
• 9.4 FUJIFILM Irvine Scientific, Inc.
• 9.5 Lonza Group
• 9.6 MP Biomedicals
• 9.7 Corning Incorporated
• 9.8 PAN-Biotech
• 9.9 R&D Systems
• 9.10 PromoCell GmbH